HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
701	18109 Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 DEC 22; 351 (3): 602-611	313	318	22	54
702	22492 Arai T, Mackenzie IRA, Hasegawa M, Nonoka T, Niizato K, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 125-136	33	33	36	43
703	25180 Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy NEUROPATHOLOGY. 2010 APR; 30 (2): 170-181	1	1	55	77
704	7388 Arai Y, Ackerley CA, Becker LE Loss of the TSC2 product tuberin in subependymal giant-cell tumors ACTA NEUROPATHOLOGICA. 1999 SEP; 98 (3): 233-239	3	13	3	24
705	9215 Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, et al. alpha-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation BRAIN RESEARCH. 2001 JAN 12; 888 (2): 287-296	57	59	19	33
706	6307 Arawaka S, Saito Y, Murayama S, Mori H Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein NEUROLOGY. 1998 SEP; 51 (3): 887-889	94	104	4	10
707	6615 Arawaka S, Sahara N, Lee G, Mori H Molecular anatomy of tau inclusions with antibodies to specifically recognize tau isoforms ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 259-265	0	0	20	36
708	7034 Arawaka S, Usami M, Sahara N, Schellenberg GD, Lee G, et al. The tau mutation (val337met) disrupts cytoskeletal networks of microtubules NEUROREPORT. 1999 APR 6; 10 (5): 993-997	23	25	12	25
709	17670 Arawaka S, Wada M, Goto S, Karube H, Sakamoto M, et al. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease JOURNAL OF NEUROSCIENCE. 2006 SEP 6; 26 (36): 9227-9238	30	35	29	41
710	24754 Arawaka S, Machiya Y, Kato T Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 158-166	0	2	49	95
#	Date / Author / Journal	LCS	GCS	LCR	CR
711	830 ARBAB MAR, WIKLUND L, SVENDGAARD NA ORIGIN AND DISTRIBUTION OF CEREBRAL VASCULAR INNERVATION FROM SUPERIOR CERVICAL, TRIGEMINAL AND SPINAL GANGLIA INVESTIGATED WITH RETROGRADE AND ANTEROGRADE WGA-HRP TRACING IN THE RAT NEUROSCIENCE. 1986 NOV; 19 (3): 695-708	4	122	3	60
712	1100 ARBAB MAR, DELGADO T, WIKLUND L, SVENDGAARD NA BRAIN-STEM TERMINATIONS OF THE TRIGEMINAL AND UPPER SPINAL GANGLIA INNERVATION OF THE CEREBROVASCULAR SYSTEM - WGA-HRP TRANSGANGLIONIC STUDY JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1988 FEB; 8 (1): 54-63	1	62	3	70
713	1120 ARBAB MAR, WIKLUND L, DELGADO T, SVENDGAARD NA STELLATE GANGLION INNERVATION OF THE VERTEBRO-BASILAR ARTERIAL SYSTEM DEMONSTRATED IN THE RAT WITH ANTEROGRADE AND RETROGRADE WGA-HRP TRACING BRAIN RESEARCH. 1988 MAR 29; 445 (1): 175-180	0	33	4	27
714	2172 ARBAB MAR, DELGADOZYGMUNT TJ, SHIOKAWA Y, SVENDGAARD NA CENTRAL PROJECTIONS OF THE SENSORY INNERVATION TO THE MIDDLE CEREBRAL- ARTERY IN THE SQUIRREL-MONKEY ACTA NEUROCHIRURGICA. 1992; 119 (1-4): 104-110	0	6	5	44
715	15675 Arbogast KB, Margulies SS, Christian CW Initial neurologic presentation in young children sustaining inflicted and unintentional fatal head injuries PEDIATRICS. 2005 JUL; 116 (1): 180-184	1	13	2	17
716	22651 Arboleda G, Morales LC, Benitez B, Arboleda H Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 333-346	0	8	18	191
717	26945 Archer T, Kostrzewa RM, Beninger RJ, Palomo T Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions NEUROTOXICITY RESEARCH. 2011 FEB; 19 (2): 211-234	0	0	99	339
718	12930 Ardley HC, Scott GB, Rose SA, Tan NGS, Markham AF, et al. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin MOLECULAR BIOLOGY OF THE CELL. 2003 NOV; 14 (11): 4541-4556	26	63	37	95
719	14045 Ardley HC, Scott GB, Rose SA, Tan NGS, Robinson PA UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 379-391	20	46	28	72
720	23963 Ardley HC Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases CURRENT PHARMACEUTICAL DESIGN. 2009 NOV; 15 (31): 3697-3715	0	5	47	303
#	Date / Author / Journal	LCS	GCS	LCR	CR
721	24034 Ardouin C, Chereau I, Llorca PM, Lhommee E, Durif F, et al. Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease REVUE NEUROLOGIQUE. 2009 NOV; 165 (11): 845-856	0	1	2	90
722	20934 Arduino D, Silva D, Cardoso SM, Chaves S, Oliveira CR, et al. New hydroxypyridinone iron-chelators as potential anti- neurodegenerative drugs FRONTIERS IN BIOSCIENCE-LANDMARK. 2008 MAY; 13: 6763-6774	0	2	7	52
723	24930 Arduino DM, Esteves AR, Oliveira CR, Cardoso SM Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinson's Disease CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 MAR; 9 (1): 105-119	0	0	26	180
724	10651 Arenas E Stem cells in the treatment of Parkinson's disease BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 795-808	21	73	21	161
725	14866 Arenas E Engineering a dopaminergic phenotype in stem/precursor cells - Role of Nurr1, glia-derived signals, and Wnts STEM CELL BIOLOGY: DEVELOPMENT AND PLASTICITY. 2005; 1049: 51-66	3	13	8	87
726	25400 Arenas E Towards stem cell replacement therapies for Parkinson's disease BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010 MAY 21; 396 (1): 152-156	0	1	16	39
727	3587 ARENDT T, BRUCKNER MK, BIGL V, MARCOVA L DENDRITIC REORGANIZATION IN THE BASAL FOREBRAIN UNDER DEGENERATIVE CONDITIONS AND ITS DEFECTS IN ALZHEIMERS-DISEASE .2. AGING, KORSAKOFFS DISEASE, PARKINSONS-DISEASE, AND ALZHEIMERS-DISEASE JOURNAL OF COMPARATIVE NEUROLOGY. 1995 JAN 9; 351 (2): 189-222	18	70	7	211
728	3955 ARENDT T, HOLZER M, GROSSMANN A, ZEDLICK D, BRUCKNER MK INCREASED EXPRESSION AND SUBCELLULAR TRANSLOCATION OF THE MITOGEN- ACTIVATED PROTEIN-KINASE KINASE AND MITOGEN-ACTIVATED PROTEIN-KINASE IN ALZHEIMERS-DISEASE NEUROSCIENCE. 1995 SEP; 68 (1): 5-18	41	85	13	126
729	4102 ARENDT T, HOLZER M, FRUTH R, BRUCKNER MK, GARTNER U PAIRED HELICAL FILAMENT-LIKE PHOSPHORYLATION OF TAU, DEPOSITION OF BETA/A4-AMYLOID AND MEMORY IMPAIRMENT IN RAT INDUCED BY CHRONIC INHIBITION OF PHOSPHATASE-1 AND PHOSPHATASE-2A NEUROSCIENCE. 1995 DEC; 69 (3): 691-698	61	92	22	58
730	5586 Arendt T, Holzer M, Gartner U, Bruckner MK Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION. 1998; : 147-158	0	35	11	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
731	5593 Arendt T, Holzer M, Gartner U Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 949-960	19	63	16	63
732	5605 Arendt T, Holzer M, Gartner U, Bruckner MK Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1998; (54): 147-158	0	0	11	82
733	5670 Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U Phosphorylation of tau, A beta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A NEUROBIOLOGY OF AGING. 1998 JAN-FEB; 19 (1): 3-13	41	51	31	77
734	6218 Arendt T, Holzer M, Bruckner MK, Janke C, Gartner U The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease NEUROSCIENCE. 1998 AUG; 85 (4): 1337-1340	12	23	10	31
735	8825 Arendt T Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain NEUROBIOLOGY OF AGING. 2000 NOV-DEC; 21 (6): 783-796	14	46	37	282
736	9078 Arendt T Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization NEUROSCIENCE. 2001; 102 (4): 723-765	14	85	91	836
737	9572 Arendt T Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2001 JUN; 19 (3): 231-245	8	35	37	280
738	12587 Arendt T, Stieler J, Strijkstra AM, Hut RA, Rudiger J, et al. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals JOURNAL OF NEUROSCIENCE. 2003 AUG 6; 23 (18): 6972-6981	31	68	13	85
739	12827 Arendt T Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity PROGRESS IN NEUROBIOLOGY. 2003 OCT; 71 (2-3): 83-248	17	65	314	3141
740	14773 Arendt T Alzheimer's disease as a disorder of dynamic brain self-organization DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378	1	11	34	161
#	Date / Author / Journal	LCS	GCS	LCR	CR
741	20733 Arevalo-Serrano J, Sanz-Anquela JM, Gonzalo-Ruiz A Beta-amyloid peptide-induced modifications in alpha 7 nicotinic acetylcholine receptor immunoreactivity in the hippocampus of the rat: Relationship with GABAergic and calcium-binding proteins perikarya BRAIN RESEARCH BULLETIN. 2008 MAR 28; 75 (5): 533-544	0	3	16	66
742	1787 ARGENYI ZB IMMUNOHISTOCHEMICAL CHARACTERIZATION OF PALISADED, ENCAPSULATED NEUROMA JOURNAL OF CUTANEOUS PATHOLOGY. 1990 DEC; 17 (6): 329-335	2	16	4	18
743	2731 ARGENYI ZB RECENT DEVELOPMENTS IN CUTANEOUS NEURAL NEOPLASMS JOURNAL OF CUTANEOUS PATHOLOGY. 1993 APR; 20 (2): 97-108	0	11	4	59
744	4598 Argenyi ZB, Rodgers J, Wick M Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles AMERICAN JOURNAL OF DERMATOPATHOLOGY. 1996 OCT; 18 (5): 460-464	0	10	2	37
745	6433 Argiles JM, Pallares-Trujillo J, Lopez-Soriano FJ The role of the ubiquitine system in the etiology of cancer and other diseases MEDICINA CLINICA. 1998 OCT 10; 111 (11): 423-426	0	1	2	23
746	22563 Arias B, Serretti A, Mandelli L, Gasto C, Catalan R, et al. Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors PHARMACOGENETICS AND GENOMICS. 2009 FEB; 19 (2): 121-128	0	8	8	63
747	2855 ARIAS C, SHARMA N, DAVIES P, SHAFITZAGARDO B OKADAIC ACID INDUCES EARLY CHANGES IN MICROTUBULE-ASSOCIATED PROTEIN-2 AND TAU-PHOSPHORYLATION PRIOR TO NEURODEGENERATION IN CULTURED CORTICAL-NEURONS JOURNAL OF NEUROCHEMISTRY. 1993 AUG; 61 (2): 673-682	55	98	3	55
748	6367 Arias C, Becerra-Garcia F, Arrieta I, Tapia R The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo EXPERIMENTAL NEUROLOGY. 1998 OCT; 153 (2): 242-254	5	19	11	52
749	21586 Arias RL, Sung MLA, Vasylyev D, Zhang MY, Albinson K, et al. Amiloride is neuroprotective in an MPTP model of Parkinson's disease NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 334-341	0	9	8	59
750	22259 Arias-Carrion O, Yamada E, Freundlieb N, Djufri M, Maurer L, et al. Neurogenesis in Substantia Nigra of Parkinsonian Brains? JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2009; (73): 279-285	0	0	6	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
751	26380 Aries MJH, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, et al. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010 NOV; 25 (11): 1186-1195	0	0	11	45
752	25924 Ariga T, Miyatake T, Yu RK Role of Proteoglycans and Glycosaminoglycans in the Pathogenesis of Alzheimer's Disease and Related Disorders: Amyloidogenesis and Therapeutic Strategies-A Review JOURNAL OF NEUROSCIENCE RESEARCH. 2010 AUG 15; 88 (11): 2303-2315	0	1	12	127
753	10837 Arikan MC, Memmott J, Broderick JA, Lafyatis R, Screaton G, et al. Modulation of the membrane-binding projection domain of tau protein: splicing regulation of exon 3 MOLECULAR BRAIN RESEARCH. 2002 MAY 30; 101 (1-2): 109-121	6	13	25	124
754	196 ARIKUNI T, SAKAI M, HAMADA I, KUBOTA K TOPOGRAPHICAL PROJECTIONS FROM THE PREFRONTAL CORTEX TO THE POST- ARCUATE AREA IN THE RHESUS-MONKEY, STUDIED BY RETROGRADE AXONAL- TRANSPORT OF HORSERADISH-PEROXIDASE NEUROSCIENCE LETTERS. 1980; 19 (2): 155-160	9	25	3	10
755	385 ARIKUNI T, SAKAI M, KUBOTA K COLUMNAR AGGREGATION OF PREFRONTAL AND ANTERIOR CINGULATE CORTICAL- CELLS PROJECTING TO THE THALAMIC MEDIODORSAL NUCLEUS IN THE MONKEY JOURNAL OF COMPARATIVE NEUROLOGY. 1983; 220 (1): 116-125	6	34	11	59
756	1232 ARIKUNI T, WATANABE K, KUBOTA K CONNECTIONS OF AREA-8 WITH AREA-6 IN THE BRAIN OF THE MACAQUE MONKEY JOURNAL OF COMPARATIVE NEUROLOGY. 1988 NOV 1; 277 (1): 21-40	11	50	14	51
757	3445 ARIKUNI T, SAKO H, MURATA A IPSILATERAL CONNECTIONS OF THE ANTERIOR CINGULATE CORTEX WITH THE FRONTAL AND MEDIAL TEMPORAL CORTICES IN THE MACAQUE MONKEY NEUROSCIENCE RESEARCH. 1994 NOV; 21 (1): 19-39	2	42	19	77
758	6434 Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, et al. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein- epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies BRAIN RESEARCH. 1998 OCT 12; 808 (1): 93-100	139	149	8	19
759	6445 Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, et al. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy ACTA NEUROPATHOLOGICA. 1998 NOV; 96 (5): 439-444	138	148	2	16
760	7131 Arima K, Nakamura M, Sunohara N, Nishio T, Ogawa M, et al. Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy brains ACTA NEUROPATHOLOGICA. 1999 JUN; 97 (6): 565-576	6	7	15	33
#	Date / Author / Journal	LCS	GCS	LCR	CR
761	7530 Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, et al. Cellular co-localization of phosphorylated tau- and NACP/alpha- synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies BRAIN RESEARCH. 1999 OCT 2; 843 (1-2): 53-61	52	60	20	32
762	8308 Arima K, Kowalska A, Hasegawa M, Mukoyama M, Watanabe R, et al. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene NEUROLOGY. 2000 MAY 9; 54 (9): 1787-1795	34	37	16	27
763	8517 Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, et al. NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies ACTA NEUROPATHOLOGICA. 2000 AUG; 100 (2): 115-121	26	27	13	20
764	19128 Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, et al. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra NEUROBIOLOGY OF AGING. 2007 JUN; 28 (6): 894-906	2	7	1	85
765	17128 Arion D, Sabatini M, Ungera T, Pastor J, Alonso-Nanclares L, et al. Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 374-387	3	27	13	94
766	22939 Arjona A, Garcia-Lopez MT Ultrasound imaging of the substantia nigra in dementia with Lewy bodies REVISTA DE NEUROLOGIA. 2009 APR 16; 48 (8): 441-442	1	1	2	4
767	12567 Arjona V, Minguez-Castellanos A, Montoro RJ, Ortega A, Escamilla F, et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease NEUROSURGERY. 2003 AUG; 53 (2): 321-328	24	40	5	38
768	10865 Arlt S, Beisiegel U, Kontush A Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease CURRENT OPINION IN LIPIDOLOGY. 2002 JUN; 13 (3): 289-294	21	59	10	61
769	10970 Arlt S, Muller-Thomsen T, Beisiegel U Use of vitamin C and E in the treatment of Alzheimer's disease DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 452-457	1	4	5	45
770	17903 Arlt S, Jahn H Pharmacological treatment of non-Alzheimer dementias CURRENT OPINION IN PSYCHIATRY. 2006 NOV; 19 (6): 642-648	0	0	4	76
#	Date / Author / Journal	LCS	GCS	LCR	CR
771	23307 Arlt S, Brassen S, Jahn H, Wilke F, Eichenlaub M, et al. Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009 JUL; 36 (7): 1090-1100	0	1	11	40
772	2856 ARMBRECHT HJ, NEMANI RK, WONGSURAWAT N PROTEIN-PHOSPHORYLATION - CHANGES WITH AGE AND AGE-RELATED DISEASES JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 1993 AUG; 41 (8): 873-879	0	6	3	65
773	20231 Armbruster C, Huber M, Prosch H, Dworan N, Attems J Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: Different features of a rare neoplasm ONKOLOGIE. 2008; 31 (4): 179-184	0	0	2	23
774	16328 Armstrong DD Epilepsy-induced microarchitectural changes in the brain PEDIATRIC AND DEVELOPMENTAL PATHOLOGY. 2005 DEC; 8 (6): 607-614	1	8	1	54
775	1896 ARMSTRONG DM, BRADY R, HERSH LB, HAYES RC, WILEY RG EXPRESSION OF CHOLINE-ACETYLTRANSFERASE AND NERVE GROWTH-FACTOR RECEPTOR WITHIN HYPOGLOSSAL MOTONEURONS FOLLOWING NERVE INJURY JOURNAL OF COMPARATIVE NEUROLOGY. 1991 FEB 22; 304 (4): 596-607	5	95	1	66
776	198 ARMSTRONG E A QUANTITATIVE COMPARISON OF THE HOMINOID THALAMUS .4. POSTERIOR ASSOCIATION NUCLEI - THE PULVINAR AND LATERAL POSTERIOR NUCLEUS AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY. 1981; 55 (3): 369-383	5	21	14	82
777	6934 Armstrong R, Cairns N, Lantos P The spatial patterns of Pick bodies, Pick cells and Alzheimer's disease pathology in Pick's disease NEUROPATHOLOGY. 1999 MAR; 19 (1): 64-70	2	4	9	25
778	3162 ARMSTRONG RA DIFFERENCES IN BETA-AMYLOID (BETA/A4) DEPOSITION IN HUMAN PATIENTS WITH DOWNS-SYNDROME AND SPORADIC ALZHEIMERS-DISEASE NEUROSCIENCE LETTERS. 1994 MAR 14; 169 (1-2): 133-136	4	17	4	33
779	3821 ARMSTRONG RA A COMPARISON OF BETA-AMYLOID (AP) DEPOSITION IN THE MEDIAL TEMPORAL- LOBE IN LATE-ONSET SPORADIC ALZHEIMERS-DISEASE, AND DOWNS-SYNDROME AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION. 1995 JUN; 2 (2): 107-113	1	6	5	34
780	4191 Armstrong RA, Winsper SJ, Blair JA Aluminium and Alzheimer's disease: Review of possible pathogenic mechanisms DEMENTIA. 1996 JAN-FEB; 7 (1): 1-9	2	36	11	107
#	Date / Author / Journal	LCS	GCS	LCR	CR
781	4324 Armstrong RA, Wood L Spatial pattern analysis of beta-amyloid (A beta) deposits in Alzheimer disease by linear regression ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 SPR; 10 (1): 40-45	0	5	4	30
782	4956 Armstrong RA, Cairns NJ, Lantos PL Dementia with Lewy bodies: Clustering of Lewy bodies in human patients NEUROSCIENCE LETTERS. 1997 MAR 7; 224 (1): 41-44	13	18	10	30
783	5314 Armstrong RA, Cairns NJ, Lantos PL Laminar distribution of cortical lewy bodies and neurofibrillary tangles in dementia with Lewy bodies NEUROSCIENCE RESEARCH COMMUNICATIONS. 1997 SEP-OCT; 21 (2): 145-152	4	10	10	26
784	5792 Armstrong RA, Cairns NJ, Lantos PL The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies EXPERIMENTAL NEUROLOGY. 1998 MAR; 150 (1): 122-127	7	10	12	32
785	5936 Armstrong RA, Cairns NJ, Lantos PL Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies ALZHEIMERS REPORTS. 1998 MAY; 1 (3): 159-163	2	3	13	27
786	6111 Armstrong RA beta-amyloid plaques: Stages in life history or independent origin? DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 1998 JUL-AUG; 9 (4): 227-238	16	48	17	128
787	9352 Armstrong RA, Cairns NJ, Lantos PL What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? NEUROPATHOLOGY. 2001 MAR; 21 (1): 1-12	9	23	21	73
788	11214 Armstrong RA, Cairns NJ, Lantos PL Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? NEUROPATHOLOGY. 2002 SEP; 22 (3): 133-146	3	3	43	105
789	12328 Armstrong RA Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis HISTOPATHOLOGY. 2003 JUN; 42 (6): 521-529	3	15	7	51
790	13334 Armstrong RA, Lantos PL, Cairns NJ Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy MOVEMENT DISORDERS. 2004 JAN; 19 (1): 109-112	11	12	8	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
791	15556 Armstrong RA, Lantos PL, Cairns NJ Overlap between neurodegenerative disorders NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124	8	22	46	150
792	16473 Armstrong RA Plaques and tangles and the pathogenesis of Alzheimer's disease FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 1-11	4	23	31	88
793	16576 Armstrong RA, Cairns NJ, Lantos PL Multiple system atrophy (MSA): Topographic distribution of the alpha- synuclein-associated pathological changes PARKINSONISM & RELATED DISORDERS. 2006; 12 (6): 356-362	6	9	10	26
794	17092 Armstrong RA, Cairns NJ Topography of alpha-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease EUROPEAN JOURNAL OF NEUROLOGY. 2006 MAY; 13 (5): 528-532	3	3	16	30
795	17573 Armstrong RA, Cairns NJ Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study using a- internexin immunohistochemistry CLINICAL NEUROPATHOLOGY. 2006 SEP-OCT; 25 (5): 209-215	1	1	9	28
796	17607 Armstrong RA, Kerty E, Skullerud K, Cairns NJ Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA) JOURNAL OF NEURAL TRANSMISSION. 2006 SEP; 113 (9): 1207-1215	4	5	11	22
797	18309 Armstrong RA, Lantos PL, Cairns NJ Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy PARKINSONISM & RELATED DISORDERS. 2007; 13 (1): 50-54	2	2	12	32
798	18828 Armstrong RA, Cairns NJ Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study JOURNAL OF NEURAL TRANSMISSION. 2007 APR; 114 (4): 451-456	1	1	13	25
799	19937 Armstrong RA, Lantos PL, Cairns NJ Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases JOURNAL OF NEURAL TRANSMISSION. 2007 DEC; 114 (12): 1569-1577	4	7	15	45
800	21459 Armstrong RA, Lantos PL, Cairns NJ What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? NEUROPATHOLOGY. 2008 AUG; 28 (4): 351-365	6	11	60	151

Date / Author / Journal

LCS

GCS

LCR

701

18109 Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al.

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 DEC 22; 351 (3): 602-611

313

318

702

22492 Arai T, Mackenzie IRA, Hasegawa M, Nonoka T, Niizato K, et al.

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies

ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 125-136

703

25180 Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, et al.

Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy

NEUROPATHOLOGY. 2010 APR; 30 (2): 170-181

704

7388 Arai Y, Ackerley CA, Becker LE

Loss of the TSC2 product tuberin in subependymal giant-cell tumors

ACTA NEUROPATHOLOGICA. 1999 SEP; 98 (3): 233-239

705

9215 Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, et al.

alpha-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation

BRAIN RESEARCH. 2001 JAN 12; 888 (2): 287-296

706

6307 Arawaka S, Saito Y, Murayama S, Mori H

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein

NEUROLOGY. 1998 SEP; 51 (3): 887-889

104

707

6615 Arawaka S, Sahara N, Lee G, Mori H

Molecular anatomy of tau inclusions with antibodies to specifically recognize tau isoforms

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 259-265

708

7034 Arawaka S, Usami M, Sahara N, Schellenberg GD, Lee G, et al.

The tau mutation (val337met) disrupts cytoskeletal networks of microtubules

NEUROREPORT. 1999 APR 6; 10 (5): 993-997

709

17670 Arawaka S, Wada M, Goto S, Karube H, Sakamoto M, et al.

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease

JOURNAL OF NEUROSCIENCE. 2006 SEP 6; 26 (36): 9227-9238

710

24754 Arawaka S, Machiya Y, Kato T

Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 158-166

Date / Author / Journal

LCS

GCS

LCR

711

830 ARBAB MAR, WIKLUND L, SVENDGAARD NA

ORIGIN AND DISTRIBUTION OF CEREBRAL VASCULAR INNERVATION FROM SUPERIOR CERVICAL, TRIGEMINAL AND SPINAL GANGLIA INVESTIGATED WITH RETROGRADE AND ANTEROGRADE WGA-HRP TRACING IN THE RAT

NEUROSCIENCE. 1986 NOV; 19 (3): 695-708

122

712

1100 ARBAB MAR, DELGADO T, WIKLUND L, SVENDGAARD NA

BRAIN-STEM TERMINATIONS OF THE TRIGEMINAL AND UPPER SPINAL GANGLIA INNERVATION OF THE CEREBROVASCULAR SYSTEM - WGA-HRP TRANSGANGLIONIC STUDY

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 1988 FEB; 8 (1): 54-63

713

1120 ARBAB MAR, WIKLUND L, DELGADO T, SVENDGAARD NA

STELLATE GANGLION INNERVATION OF THE VERTEBRO-BASILAR ARTERIAL SYSTEM DEMONSTRATED IN THE RAT WITH ANTEROGRADE AND RETROGRADE WGA-HRP TRACING

BRAIN RESEARCH. 1988 MAR 29; 445 (1): 175-180

714

2172 ARBAB MAR, DELGADOZYGMUNT TJ, SHIOKAWA Y, SVENDGAARD NA

CENTRAL PROJECTIONS OF THE SENSORY INNERVATION TO THE MIDDLE CEREBRAL- ARTERY IN THE SQUIRREL-MONKEY

ACTA NEUROCHIRURGICA. 1992; 119 (1-4): 104-110

715

15675 Arbogast KB, Margulies SS, Christian CW

Initial neurologic presentation in young children sustaining inflicted and unintentional fatal head injuries

PEDIATRICS. 2005 JUL; 116 (1): 180-184

716

22651 Arboleda G, Morales LC, Benitez B, Arboleda H

Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration

BRAIN RESEARCH REVIEWS. 2009 MAR; 59 (2): 333-346

191

717

26945 Archer T, Kostrzewa RM, Beninger RJ, Palomo T

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

NEUROTOXICITY RESEARCH. 2011 FEB; 19 (2): 211-234

339

718

12930 Ardley HC, Scott GB, Rose SA, Tan NGS, Markham AF, et al.

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

MOLECULAR BIOLOGY OF THE CELL. 2003 NOV; 14 (11): 4541-4556

719

14045 Ardley HC, Scott GB, Rose SA, Tan NGS, Robinson PA

UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 379-391

720

23963 Ardley HC

Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases

CURRENT PHARMACEUTICAL DESIGN. 2009 NOV; 15 (31): 3697-3715

303

Date / Author / Journal

LCS

GCS

LCR

721

24034 Ardouin C, Chereau I, Llorca PM, Lhommee E, Durif F, et al.

Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease

REVUE NEUROLOGIQUE. 2009 NOV; 165 (11): 845-856

722

20934 Arduino D, Silva D, Cardoso SM, Chaves S, Oliveira CR, et al.

New hydroxypyridinone iron-chelators as potential anti- neurodegenerative drugs

FRONTIERS IN BIOSCIENCE-LANDMARK. 2008 MAY; 13: 6763-6774

723

24930 Arduino DM, Esteves AR, Oliveira CR, Cardoso SM

Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinson's Disease

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 MAR; 9 (1): 105-119

180

724

10651 Arenas E

Stem cells in the treatment of Parkinson's disease

BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 795-808

161

725

14866 Arenas E

Engineering a dopaminergic phenotype in stem/precursor cells - Role of Nurr1, glia-derived signals, and Wnts

STEM CELL BIOLOGY: DEVELOPMENT AND PLASTICITY. 2005; 1049: 51-66

726

25400 Arenas E

Towards stem cell replacement therapies for Parkinson's disease

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010 MAY 21; 396 (1): 152-156

727

3587 ARENDT T, BRUCKNER MK, BIGL V, MARCOVA L

DENDRITIC REORGANIZATION IN THE BASAL FOREBRAIN UNDER DEGENERATIVE CONDITIONS AND ITS DEFECTS IN ALZHEIMERS-DISEASE .2. AGING, KORSAKOFFS DISEASE, PARKINSONS-DISEASE, AND ALZHEIMERS-DISEASE

JOURNAL OF COMPARATIVE NEUROLOGY. 1995 JAN 9; 351 (2): 189-222

211

728

3955 ARENDT T, HOLZER M, GROSSMANN A, ZEDLICK D, BRUCKNER MK

INCREASED EXPRESSION AND SUBCELLULAR TRANSLOCATION OF THE MITOGEN- ACTIVATED PROTEIN-KINASE KINASE AND MITOGEN-ACTIVATED PROTEIN-KINASE IN ALZHEIMERS-DISEASE

NEUROSCIENCE. 1995 SEP; 68 (1): 5-18

126

729

4102 ARENDT T, HOLZER M, FRUTH R, BRUCKNER MK, GARTNER U

PAIRED HELICAL FILAMENT-LIKE PHOSPHORYLATION OF TAU, DEPOSITION OF BETA/A4-AMYLOID AND MEMORY IMPAIRMENT IN RAT INDUCED BY CHRONIC INHIBITION OF PHOSPHATASE-1 AND PHOSPHATASE-2A

NEUROSCIENCE. 1995 DEC; 69 (3): 691-698

730

5586 Arendt T, Holzer M, Gartner U, Bruckner MK

Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION. 1998; : 147-158

Date / Author / Journal

LCS

GCS

LCR

731

5593 Arendt T, Holzer M, Gartner U

Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 949-960

732

5605 Arendt T, Holzer M, Gartner U, Bruckner MK

Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1998; (54): 147-158

733

5670 Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U

Phosphorylation of tau, A beta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A

NEUROBIOLOGY OF AGING. 1998 JAN-FEB; 19 (1): 3-13

734

6218 Arendt T, Holzer M, Bruckner MK, Janke C, Gartner U

The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease

NEUROSCIENCE. 1998 AUG; 85 (4): 1337-1340

735

8825 Arendt T

Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain

NEUROBIOLOGY OF AGING. 2000 NOV-DEC; 21 (6): 783-796

282

736

9078 Arendt T

Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization

NEUROSCIENCE. 2001; 102 (4): 723-765

836

737

9572 Arendt T

Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2001 JUN; 19 (3): 231-245

280

738

12587 Arendt T, Stieler J, Strijkstra AM, Hut RA, Rudiger J, et al.

Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals

JOURNAL OF NEUROSCIENCE. 2003 AUG 6; 23 (18): 6972-6981

739

12827 Arendt T

Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity

PROGRESS IN NEUROBIOLOGY. 2003 OCT; 71 (2-3): 83-248

314

3141

740

14773 Arendt T

Alzheimer's disease as a disorder of dynamic brain self-organization

DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378

161

Date / Author / Journal

LCS

GCS

LCR

741

20733 Arevalo-Serrano J, Sanz-Anquela JM, Gonzalo-Ruiz A

Beta-amyloid peptide-induced modifications in alpha 7 nicotinic acetylcholine receptor immunoreactivity in the hippocampus of the rat: Relationship with GABAergic and calcium-binding proteins perikarya

BRAIN RESEARCH BULLETIN. 2008 MAR 28; 75 (5): 533-544

742

1787 ARGENYI ZB

IMMUNOHISTOCHEMICAL CHARACTERIZATION OF PALISADED, ENCAPSULATED NEUROMA

JOURNAL OF CUTANEOUS PATHOLOGY. 1990 DEC; 17 (6): 329-335

743

2731 ARGENYI ZB

RECENT DEVELOPMENTS IN CUTANEOUS NEURAL NEOPLASMS

JOURNAL OF CUTANEOUS PATHOLOGY. 1993 APR; 20 (2): 97-108

744

4598 Argenyi ZB, Rodgers J, Wick M

Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles

AMERICAN JOURNAL OF DERMATOPATHOLOGY. 1996 OCT; 18 (5): 460-464

745

6433 Argiles JM, Pallares-Trujillo J, Lopez-Soriano FJ

The role of the ubiquitine system in the etiology of cancer and other diseases

MEDICINA CLINICA. 1998 OCT 10; 111 (11): 423-426

746

22563 Arias B, Serretti A, Mandelli L, Gasto C, Catalan R, et al.

Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors

PHARMACOGENETICS AND GENOMICS. 2009 FEB; 19 (2): 121-128

747

2855 ARIAS C, SHARMA N, DAVIES P, SHAFITZAGARDO B

OKADAIC ACID INDUCES EARLY CHANGES IN MICROTUBULE-ASSOCIATED PROTEIN-2 AND TAU-PHOSPHORYLATION PRIOR TO NEURODEGENERATION IN CULTURED CORTICAL-NEURONS

JOURNAL OF NEUROCHEMISTRY. 1993 AUG; 61 (2): 673-682

748

6367 Arias C, Becerra-Garcia F, Arrieta I, Tapia R

The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo

EXPERIMENTAL NEUROLOGY. 1998 OCT; 153 (2): 242-254

749

21586 Arias RL, Sung MLA, Vasylyev D, Zhang MY, Albinson K, et al.

Amiloride is neuroprotective in an MPTP model of Parkinson's disease

NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 334-341

750

22259 Arias-Carrion O, Yamada E, Freundlieb N, Djufri M, Maurer L, et al.

Neurogenesis in Substantia Nigra of Parkinsonian Brains?

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2009; (73): 279-285

Date / Author / Journal

LCS

GCS

LCR

751

26380 Aries MJH, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, et al.

Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010 NOV; 25 (11): 1186-1195

752

25924 Ariga T, Miyatake T, Yu RK

Role of Proteoglycans and Glycosaminoglycans in the Pathogenesis of Alzheimer's Disease and Related Disorders: Amyloidogenesis and Therapeutic Strategies-A Review

JOURNAL OF NEUROSCIENCE RESEARCH. 2010 AUG 15; 88 (11): 2303-2315

127

753

10837 Arikan MC, Memmott J, Broderick JA, Lafyatis R, Screaton G, et al.

Modulation of the membrane-binding projection domain of tau protein: splicing regulation of exon 3

MOLECULAR BRAIN RESEARCH. 2002 MAY 30; 101 (1-2): 109-121

124

754

196 ARIKUNI T, SAKAI M, HAMADA I, KUBOTA K

TOPOGRAPHICAL PROJECTIONS FROM THE PREFRONTAL CORTEX TO THE POST- ARCUATE AREA IN THE RHESUS-MONKEY, STUDIED BY RETROGRADE AXONAL- TRANSPORT OF HORSERADISH-PEROXIDASE

NEUROSCIENCE LETTERS. 1980; 19 (2): 155-160

755

385 ARIKUNI T, SAKAI M, KUBOTA K

COLUMNAR AGGREGATION OF PREFRONTAL AND ANTERIOR CINGULATE CORTICAL- CELLS PROJECTING TO THE THALAMIC MEDIODORSAL NUCLEUS IN THE MONKEY

JOURNAL OF COMPARATIVE NEUROLOGY. 1983; 220 (1): 116-125

756

1232 ARIKUNI T, WATANABE K, KUBOTA K

CONNECTIONS OF AREA-8 WITH AREA-6 IN THE BRAIN OF THE MACAQUE MONKEY

JOURNAL OF COMPARATIVE NEUROLOGY. 1988 NOV 1; 277 (1): 21-40

757

3445 ARIKUNI T, SAKO H, MURATA A

IPSILATERAL CONNECTIONS OF THE ANTERIOR CINGULATE CORTEX WITH THE FRONTAL AND MEDIAL TEMPORAL CORTICES IN THE MACAQUE MONKEY

NEUROSCIENCE RESEARCH. 1994 NOV; 21 (1): 19-39

758

6434 Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, et al.

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein- epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

BRAIN RESEARCH. 1998 OCT 12; 808 (1): 93-100

139

149

759

6445 Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, et al.

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

ACTA NEUROPATHOLOGICA. 1998 NOV; 96 (5): 439-444

138

148

760

7131 Arima K, Nakamura M, Sunohara N, Nishio T, Ogawa M, et al.

Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy brains

ACTA NEUROPATHOLOGICA. 1999 JUN; 97 (6): 565-576

Date / Author / Journal

LCS

GCS

LCR

761

7530 Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, et al.

Cellular co-localization of phosphorylated tau- and NACP/alpha- synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

BRAIN RESEARCH. 1999 OCT 2; 843 (1-2): 53-61

762

8308 Arima K, Kowalska A, Hasegawa M, Mukoyama M, Watanabe R, et al.

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene

NEUROLOGY. 2000 MAY 9; 54 (9): 1787-1795

763

8517 Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, et al.

NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies

ACTA NEUROPATHOLOGICA. 2000 AUG; 100 (2): 115-121

764

19128 Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, et al.

Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra

NEUROBIOLOGY OF AGING. 2007 JUN; 28 (6): 894-906

765

17128 Arion D, Sabatini M, Ungera T, Pastor J, Alonso-Nanclares L, et al.

Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy

NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 374-387

766

22939 Arjona A, Garcia-Lopez MT

Ultrasound imaging of the substantia nigra in dementia with Lewy bodies

REVISTA DE NEUROLOGIA. 2009 APR 16; 48 (8): 441-442

767

12567 Arjona V, Minguez-Castellanos A, Montoro RJ, Ortega A, Escamilla F, et al.

Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease

NEUROSURGERY. 2003 AUG; 53 (2): 321-328

768

10865 Arlt S, Beisiegel U, Kontush A

Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease

CURRENT OPINION IN LIPIDOLOGY. 2002 JUN; 13 (3): 289-294

769

10970 Arlt S, Muller-Thomsen T, Beisiegel U

Use of vitamin C and E in the treatment of Alzheimer's disease

DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 452-457

770

17903 Arlt S, Jahn H

Pharmacological treatment of non-Alzheimer dementias

CURRENT OPINION IN PSYCHIATRY. 2006 NOV; 19 (6): 642-648

Date / Author / Journal

LCS

GCS

LCR

771

23307 Arlt S, Brassen S, Jahn H, Wilke F, Eichenlaub M, et al.

Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009 JUL; 36 (7): 1090-1100

772

2856 ARMBRECHT HJ, NEMANI RK, WONGSURAWAT N

PROTEIN-PHOSPHORYLATION - CHANGES WITH AGE AND AGE-RELATED DISEASES

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 1993 AUG; 41 (8): 873-879

773

20231 Armbruster C, Huber M, Prosch H, Dworan N, Attems J

Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: Different features of a rare neoplasm

ONKOLOGIE. 2008; 31 (4): 179-184

774

16328 Armstrong DD

Epilepsy-induced microarchitectural changes in the brain

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY. 2005 DEC; 8 (6): 607-614

775

1896 ARMSTRONG DM, BRADY R, HERSH LB, HAYES RC, WILEY RG

EXPRESSION OF CHOLINE-ACETYLTRANSFERASE AND NERVE GROWTH-FACTOR RECEPTOR WITHIN HYPOGLOSSAL MOTONEURONS FOLLOWING NERVE INJURY

JOURNAL OF COMPARATIVE NEUROLOGY. 1991 FEB 22; 304 (4): 596-607

776

198 ARMSTRONG E

A QUANTITATIVE COMPARISON OF THE HOMINOID THALAMUS .4. POSTERIOR ASSOCIATION NUCLEI - THE PULVINAR AND LATERAL POSTERIOR NUCLEUS

AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY. 1981; 55 (3): 369-383

777

6934 Armstrong R, Cairns N, Lantos P

The spatial patterns of Pick bodies, Pick cells and Alzheimer's disease pathology in Pick's disease

NEUROPATHOLOGY. 1999 MAR; 19 (1): 64-70

778

3162 ARMSTRONG RA

DIFFERENCES IN BETA-AMYLOID (BETA/A4) DEPOSITION IN HUMAN PATIENTS WITH DOWNS-SYNDROME AND SPORADIC ALZHEIMERS-DISEASE

NEUROSCIENCE LETTERS. 1994 MAR 14; 169 (1-2): 133-136

779

3821 ARMSTRONG RA

A COMPARISON OF BETA-AMYLOID (AP) DEPOSITION IN THE MEDIAL TEMPORAL- LOBE IN LATE-ONSET SPORADIC ALZHEIMERS-DISEASE, AND DOWNS-SYNDROME

AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION. 1995 JUN; 2 (2): 107-113

780

4191 Armstrong RA, Winsper SJ, Blair JA

Aluminium and Alzheimer's disease: Review of possible pathogenic mechanisms

DEMENTIA. 1996 JAN-FEB; 7 (1): 1-9

107

Date / Author / Journal

LCS

GCS

LCR

781

4324 Armstrong RA, Wood L

Spatial pattern analysis of beta-amyloid (A beta) deposits in Alzheimer disease by linear regression

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 SPR; 10 (1): 40-45

782

4956 Armstrong RA, Cairns NJ, Lantos PL

Dementia with Lewy bodies: Clustering of Lewy bodies in human patients

NEUROSCIENCE LETTERS. 1997 MAR 7; 224 (1): 41-44

783

5314 Armstrong RA, Cairns NJ, Lantos PL

Laminar distribution of cortical lewy bodies and neurofibrillary tangles in dementia with Lewy bodies

NEUROSCIENCE RESEARCH COMMUNICATIONS. 1997 SEP-OCT; 21 (2): 145-152

784

5792 Armstrong RA, Cairns NJ, Lantos PL

The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies

EXPERIMENTAL NEUROLOGY. 1998 MAR; 150 (1): 122-127

785

5936 Armstrong RA, Cairns NJ, Lantos PL

Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies

ALZHEIMERS REPORTS. 1998 MAY; 1 (3): 159-163

786

6111 Armstrong RA

beta-amyloid plaques: Stages in life history or independent origin?

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 1998 JUL-AUG; 9 (4): 227-238

128

787

9352 Armstrong RA, Cairns NJ, Lantos PL

What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders?

NEUROPATHOLOGY. 2001 MAR; 21 (1): 1-12

788

11214 Armstrong RA, Cairns NJ, Lantos PL

Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration?

NEUROPATHOLOGY. 2002 SEP; 22 (3): 133-146

105

789

12328 Armstrong RA

Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis

HISTOPATHOLOGY. 2003 JUN; 42 (6): 521-529

790

13334 Armstrong RA, Lantos PL, Cairns NJ

Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy

MOVEMENT DISORDERS. 2004 JAN; 19 (1): 109-112

Date / Author / Journal

LCS

GCS

LCR

791

15556 Armstrong RA, Lantos PL, Cairns NJ

Overlap between neurodegenerative disorders

NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124

150

792

16473 Armstrong RA

Plaques and tangles and the pathogenesis of Alzheimer's disease

FOLIA NEUROPATHOLOGICA. 2006; 44 (1): 1-11

793

16576 Armstrong RA, Cairns NJ, Lantos PL

Multiple system atrophy (MSA): Topographic distribution of the alpha- synuclein-associated pathological changes

PARKINSONISM & RELATED DISORDERS. 2006; 12 (6): 356-362

794

17092 Armstrong RA, Cairns NJ

Topography of alpha-internexin-positive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease

EUROPEAN JOURNAL OF NEUROLOGY. 2006 MAY; 13 (5): 528-532

795

17573 Armstrong RA, Cairns NJ

Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study using a- internexin immunohistochemistry

CLINICAL NEUROPATHOLOGY. 2006 SEP-OCT; 25 (5): 209-215

796

17607 Armstrong RA, Kerty E, Skullerud K, Cairns NJ

Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA)

JOURNAL OF NEURAL TRANSMISSION. 2006 SEP; 113 (9): 1207-1215

797

18309 Armstrong RA, Lantos PL, Cairns NJ

Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy

PARKINSONISM & RELATED DISORDERS. 2007; 13 (1): 50-54

798

18828 Armstrong RA, Cairns NJ

Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study

JOURNAL OF NEURAL TRANSMISSION. 2007 APR; 114 (4): 451-456

799

19937 Armstrong RA, Lantos PL, Cairns NJ

Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases

JOURNAL OF NEURAL TRANSMISSION. 2007 DEC; 114 (12): 1569-1577

800

21459 Armstrong RA, Lantos PL, Cairns NJ

What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?

NEUROPATHOLOGY. 2008 AUG; 28 (4): 351-365

151

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records